Patient & Visitor InformationContact Us
  •  Cardiothoracic Surgery Header

  • Transcatheter Aortic Valve Replacement (TAVR)

  •       TAVR
      Edwards Lifesciences LLC,
    Irvine, CA

    Transcatheter aortic valve replacement (TAVR) is an innovative, non-surgical alternative for patients with severe aortic stenosis, offered through the Cardiovascular Institute’s cardiovascular surgery program, located on the Rhode Island Hospital campus.

    Our program was the first in Rhode Island and among the first in New England to offer this cutting-edge, non-invasive alternative to patients in need of valve replacement, yet considered too high-risk for open-heart surgery.

    Our TAVR procedures (both from a transfemoral approach and transapical approach) have outcomes similar to those of the PARTNER (Placement of ARotic TraNcathER Valves) Trial sites, which were the world’s first sites to perform TAVR.

    “The results are very gratifying,” explained Frank Sellke, MD, chief of cardiothoracic surgery at Rhode Island Hospital. “Patients who were not able to have a surgical valve replacement in the past are now able to receive the best treatment possible with the TAVR procedure.”

    The procedure replaces a narrowed or diseased aortic heart valve through a catheter inserted in the thigh. A new valve is fed through the catheter to the heart, in effect, replacing the valve from the inside.

    Until now, patients who could not undergo open-heart surgery would be treated with maintenance medications, rather than surgically repair or replace the diseased valve. TAVR is performed in an operating room by an interventional cardiologist with support from our highly experienced, multidisciplinary cardiothoracic surgery staff.

    For more information, or to refer a patient, please feel free to contact us at 1-855-384-8287 or email

    Read More

    Rhode Island Hospital Performs Its First Non-Surgical Heart Valve Replacement For Patients With Diseased Heart Valves